212 related articles for article (PubMed ID: 3927692)
1. Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris.
Kamikawa T; Kobayashi A; Yamashita T; Hayashi H; Yamazaki N
Am J Cardiol; 1985 Aug; 56(4):247-51. PubMed ID: 3927692
[TBL] [Abstract][Full Text] [Related]
2. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.
Winsor T; Berger HJ
Am Heart J; 1975 Nov; 90(5):611-26. PubMed ID: 811102
[TBL] [Abstract][Full Text] [Related]
3. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
Parker JD; Parker AB; Farrell B; Parker JO
Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
[TBL] [Abstract][Full Text] [Related]
4. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.
Rezaković DE; Pavicić L; Majacić M
Eur Heart J; 1988 Jan; 9 Suppl A():73-81. PubMed ID: 3137073
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F
Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635
[TBL] [Abstract][Full Text] [Related]
6. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
7. Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial.
Crean PA; Ribeiro P; Crea F; Davies GJ; Ratcliffe D; Maseri A
Am Heart J; 1984 Dec; 108(6):1494-500. PubMed ID: 6439019
[TBL] [Abstract][Full Text] [Related]
8. Randomized double-blind study of pindolol in patients with stable angina pectoris.
Harston WE; Friesinger GC
Am Heart J; 1982 Aug; 104(2 Pt 2):504-11. PubMed ID: 7102537
[TBL] [Abstract][Full Text] [Related]
9. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
10. Effects of bepridil on exercise tolerance in chronic stable angina: a double-blind, randomized, placebo-controlled, crossover trial.
Hill JA; O'Brien JT; Scott E; Conti CR; Pepine CJ
Am J Cardiol; 1984 Mar; 53(6):679-83. PubMed ID: 6367414
[TBL] [Abstract][Full Text] [Related]
11. Treatment of stable angina of effort with verapamil: a double-blind, placebo-controlled randomized crossover study.
Brodsky SJ; Cutler SS; Weiner DA; McCabe CH; Ryan TJ; Klein MD
Circulation; 1982 Sep; 66(3):569-74. PubMed ID: 6807568
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral sustained-release nitroglycerin on exercise capacity in angina pectoris: dose-response relation and duration of action during double-blind crossover randomized acute therapy.
Degré SG; Strappart GM; Sobolski JC; Berkenboom GM; Stoupel EE; Vandermoten PP
Am J Cardiol; 1983 Jun; 51(10):1595-8. PubMed ID: 6407293
[TBL] [Abstract][Full Text] [Related]
13. Effect of a new transdermal therapeutic system containing nitroglycerin on exercise capacity in patients with angina pectoris.
Scardi S; Pivotti F; Fonda F; Pandullo C; Castelli M; Pollavini G
Am Heart J; 1985 Sep; 110(3):546-51. PubMed ID: 3929579
[TBL] [Abstract][Full Text] [Related]
14. Exercise capacity with transdermal nitroglycerin in patients with stable angina pectoris.
Naafs MA; de Boer AC; Koster RW; Klazen CW; Dunning AJ
Eur Heart J; 1984 Sep; 5(9):705-9. PubMed ID: 6437815
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the effect of nifedipine versus diltiazem on exercise performance, serum propranolol levels, and ST-segment abnormalities in patients with chronic stable angina taking propranolol.
Robinson K; Krikler S; Krikler DM
Am J Cardiol; 1989 Sep; 64(11):27F-30F. PubMed ID: 2782269
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of sustained-release diltiazem in stable angina pectoris.
Weiner DA; Cutler SS; Klein MD
Am J Cardiol; 1986 Jan; 57(1):6-9. PubMed ID: 3510525
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antianginal efficacies and exercise hemodynamic effects of nifedipine and diltiazem in stable angina pectoris.
Wallace WA; Wellington KL; Murphy GW; Liang CS
Am J Cardiol; 1989 Feb; 63(7):414-8. PubMed ID: 2492741
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of PY 108-068, a new calcium channel blocker, for angina pectoris.
de Buitleir M; Krikler S; Krikler DM
Am J Cardiol; 1986 Jan; 57(1):15-9. PubMed ID: 3079940
[TBL] [Abstract][Full Text] [Related]
19. Oral sustained-release nitroglycerin in chronic stable angina: a multicenter, double-blind, randomized crossover trial.
Berkenboom GM; Sobolski JC; Degre SG
Am J Cardiol; 1984 Jan; 53(1):15-7. PubMed ID: 6419574
[TBL] [Abstract][Full Text] [Related]
20. Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension.
Frishman WH; Charlap S; Goldberger J; Kimmel B; Stroh J; Dorsa F; Allen L; Strom J
Am J Cardiol; 1985 Dec; 56(16):41H-46H. PubMed ID: 3934948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
